[go: up one dir, main page]

DK1003525T3 - Præparat og fremgangsmåde til regulering af celleproliferation og celledød - Google Patents

Præparat og fremgangsmåde til regulering af celleproliferation og celledød

Info

Publication number
DK1003525T3
DK1003525T3 DK98938555T DK98938555T DK1003525T3 DK 1003525 T3 DK1003525 T3 DK 1003525T3 DK 98938555 T DK98938555 T DK 98938555T DK 98938555 T DK98938555 T DK 98938555T DK 1003525 T3 DK1003525 T3 DK 1003525T3
Authority
DK
Denmark
Prior art keywords
composition
cell
preparation
controlling
dna
Prior art date
Application number
DK98938555T
Other languages
Danish (da)
English (en)
Inventor
Nigel C Phillips
Mario C Filion
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Application granted granted Critical
Publication of DK1003525T3 publication Critical patent/DK1003525T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK98938555T 1997-08-05 1998-08-05 Præparat og fremgangsmåde til regulering af celleproliferation og celledød DK1003525T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5477797P 1997-08-05 1997-08-05
US7506798P 1998-02-18 1998-02-18
US7511198P 1998-02-18 1998-02-18
US8631798P 1998-05-21 1998-05-21
PCT/CA1998/000744 WO1999007383A1 (en) 1997-08-05 1998-08-05 Composition and method for regulating cell proliferation and cell death

Publications (1)

Publication Number Publication Date
DK1003525T3 true DK1003525T3 (da) 2003-03-24

Family

ID=27489673

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98938555T DK1003525T3 (da) 1997-08-05 1998-08-05 Præparat og fremgangsmåde til regulering af celleproliferation og celledød

Country Status (17)

Country Link
US (2) US6329347B1 (ja)
EP (1) EP1003525B1 (ja)
JP (2) JP4335435B2 (ja)
KR (1) KR100533576B1 (ja)
AT (1) ATE227996T1 (ja)
AU (1) AU736450B2 (ja)
BR (1) BR9815602A (ja)
CA (1) CA2299548C (ja)
DE (1) DE69809561T2 (ja)
DK (1) DK1003525T3 (ja)
ES (1) ES2187047T3 (ja)
HU (1) HU227921B1 (ja)
IL (3) IL134371A0 (ja)
NO (1) NO322450B1 (ja)
NZ (1) NZ502674A (ja)
PT (1) PT1003525E (ja)
WO (1) WO1999007383A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1003525E (pt) 1997-08-05 2003-03-31 Bioniche Life Sciences Inc Composicao e metodo para a regulacao da proliferacao e da morte celular
ATE290390T1 (de) * 1998-02-18 2005-03-15 Bioniche Life Sciences Inc Behandlung des harnblasenkrebses durch mycobacterium phlei zellwand
NZ511941A (en) * 1998-12-04 2003-04-29 Bioniche Life Sciences Inc Use of Mycobacterium phlei DNA in chemotherapeutic compositions
JP4488626B2 (ja) * 1998-12-04 2010-06-23 バイオニケ ライフ サイエンシーズ インコーポレイテッド 炎症の治療法
US6809081B1 (en) 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
US6794368B1 (en) * 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
PT1165106E (pt) * 1999-04-01 2005-10-31 Bioniche Life Sciences Inc Composicoes e metodo para induzir apoptose em celulas de cancro da prostata, por m-adn e mcc
DK1181304T3 (da) 1999-04-08 2008-02-11 Antisoma Res Ltd Antiproliferativ virkning af G-rige oligonucleotider samt fremgangsmåde til anvendelse af dem til binding af nucleolin
AU7501700A (en) * 1999-09-29 2001-04-30 Bioniche Life Sciences Inc. Method to disrupt mitochondrial function
MXPA02005842A (es) * 1999-12-13 2003-10-14 Bioniche Life Sciences Inc Oligonucleotidos sinteticos terapeuticamente utiles.
NZ520312A (en) * 1999-12-28 2003-08-29 Bioniche Life Sciences Inc Hyaluronic acid in the treatment of cancer
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls
US6673566B1 (en) 2002-01-10 2004-01-06 The United States Of America As Represented By The Secretary Of Agriculture Diagnosis of pathogen infections through analysis of nitrite production by antigen stimulated leukocytes
ES2569066T3 (es) * 2006-07-25 2016-05-06 Lipoxen Technologies Limited Conjugación N-terminal de ácido polisiálico a proteínas
ES2829416T3 (es) 2010-10-13 2021-05-31 Telesta Therapeutics Inc Composiciones de pared celular del ácido ribonucleico bacteriano y procedimientos para prepararlas y usarlas

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US4152423A (en) 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
FR2160326B1 (ja) 1971-11-19 1975-02-07 Anvar
CH602920A5 (ja) 1973-02-23 1978-08-15 Wellcome Found
US3976544A (en) 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042A1 (fr) 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
JPS54140710A (en) 1978-03-10 1979-11-01 Mitsui Toatsu Chem Inc Anti-tumor substance and its preparation
DE3011461C2 (de) 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
US4520019A (en) 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4744984A (en) 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
EP0681479B1 (en) 1993-01-29 1999-04-28 Vetrepharm, Inc. Immunotherapeutic composition
PT1003525E (pt) 1997-08-05 2003-03-31 Bioniche Life Sciences Inc Composicao e metodo para a regulacao da proliferacao e da morte celular

Also Published As

Publication number Publication date
AU736450B2 (en) 2001-07-26
KR20010022643A (ko) 2001-03-26
JP2008208140A (ja) 2008-09-11
DE69809561D1 (de) 2003-01-02
BR9815602A (pt) 2001-12-11
HU227921B1 (hu) 2012-06-28
NZ502674A (en) 2002-06-28
CA2299548C (en) 2009-12-29
JP2001513504A (ja) 2001-09-04
WO1999007383A1 (en) 1999-02-18
DE69809561T2 (de) 2003-09-25
EP1003525A1 (en) 2000-05-31
ATE227996T1 (de) 2002-12-15
NO20000576D0 (no) 2000-02-04
HUP0003012A2 (hu) 2000-12-28
PT1003525E (pt) 2003-03-31
WO1999007383B1 (en) 1999-03-25
JP4335435B2 (ja) 2009-09-30
IL180924A (en) 2010-11-30
CA2299548A1 (en) 1999-02-18
NO20000576L (no) 2000-04-04
KR100533576B1 (ko) 2005-12-05
AU8723698A (en) 1999-03-01
IL134371A0 (en) 2001-04-30
EP1003525B1 (en) 2002-11-20
ES2187047T3 (es) 2003-05-16
IL134371A (en) 2007-07-24
NO322450B1 (no) 2006-10-09
US6326357B1 (en) 2001-12-04
IL180924A0 (en) 2007-07-04
HUP0003012A3 (en) 2004-03-29
US6329347B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
IL180924A0 (en) Method for regulating cell proliferation and cell death
DE60031997D1 (de) Umkehrtransfektionsverfahren
DE68915070D1 (de) Zellkultur-Reaktor.
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
DK0389063T4 (da) Fremgangsmåde til isolering af nukleinsyre
DE69019009D1 (de) Zellkulturverfahren.
DK240088D0 (da) Fremgangsmaade til transformation af et plantecellematerale
EP1411118A4 (en) Cell proliferation inhibitors with anti-glycanic-3 antibody
DK1681355T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
ATE268904T1 (de) Zellbasiertes festphasentest
FI886050A7 (fi) Amperometrinen menetelmä 1,4-dihydronikotiiniamidiadeniinidinukleotidin (NADH) kvantitatiiviseksi määrittämiseksi liuoksessa
DE3751280D1 (de) Enzyme als landwirtschaftliche chemische Hilfsmittel.
GB9825096D0 (en) Cells,culture methods and their uses
DE3887456D1 (de) Elektrochemische Zelle.
NO872420D0 (no) Elektrokjemisk cellesammensetning.
DE3765765D1 (de) Polymere als beizmittel fuer saure farbstoffe.
DK323088A (da) Koeleanlaeg til braendeselsceller
IT8721047A0 (it) Dispositivo per culture microbiologiche.
DK0626131T3 (da) Staldgulv til anvendelse over en gødningsgrav og/eller en gødningskanal; gulvplade til dannelse af et staldgulv og stald, s
IT8567141A1 (it) Procedimento per le coltura di cellule, mediante dispersione di gas.
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
NL190728C (nl) Elektrodestructuur voor elektrochemische cellen.
ITRM930073A0 (it) Metodo di propagazione in vitro di cellule til.
FR2657879B1 (fr) Plaque de culture cellulaire.
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen